Indian J Med Microbiol Close
 

Table 1: Comparing the advantages of disadvantages of using docetaxel, abiraterone, enzalutamide, and apalutamide in metastatic hormone-sensitive prostate cancer

Table 1: Comparing the advantages of disadvantages of using docetaxel, abiraterone, enzalutamide, and apalutamide in metastatic hormone-sensitive prostate cancer